Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001571049-14-002064
Filing Date
2014-05-23
Accepted
2014-05-23 17:03:49
Documents
1
Period of Report
2014-05-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1400992_dupform4-x2.html 4  
1 OWNERSHIP DOCUMENT t1400992_dupform4-x2.xml 4 3958
  Complete submission text file 0001571049-14-002064.txt   5439
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PINE STREET PHILADELPHIA PA 19106
Business Address
UPRICHARD DAVID C (Reporting) CIK: 0001239916 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 14867827